Physician profile
Ankur Sethi
NPI 1013172329
$34,409.13
in general payments reported to CMS, 2019-2025
25 companies · $6,461 in 2025
The $6,461 reported for 2025 was more than what 86% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,318 · 2020: $2,499 · 2021: $2,341 · 2022: $2,220 · 2023: $7,474 · 2024: $5,097 · 2025: $6,461.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $7,321 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,428.85 |
| Travel and Lodging | $7,320.87 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $9,898.96 | 2019-2025 | Evoque, Sapien 3 Ultra Resilia, Pascal |
| Abbott Laboratories | $8,918.16 | 2019-2025 | Navitor, Triclip, Portico |
| Boston Scientific Corporation | $4,007.86 | 2019-2025 | Avvigo Guidance System, Mamba, Comet |
| Abiomed | $3,521.82 | 2021-2025 | Impella |
| Medtronic Vascular, INC. | $2,561.91 | 2019-2020 | |
| Penumbra, INC. | $2,348.12 | 2019 | |
| Angiodynamics, INC. | $1,509.84 | 2025 | Angiovac |
| Shockwave Medical, INC | $370.19 | 2019-2023 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Medtronic, INC. | $283.72 | 2021-2025 | Corevalve Evolut R |
| Cardiovascular Systems INC. | $250.30 | 2019-2022 | |
| Cardiva Medical, INC. | $178.77 | 2022-2025 | Cardiva Vascade 6/7f Vcs |
| Irhythm Technologies, INC. | $145.74 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Astrazeneca Pharmaceuticals Lp | $103.80 | 2021 | |
| Amgen INC. | $87.15 | 2019-2023 | Repatha |
| Philips North America LLC | $47.41 | 2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $30.03 | 2020-2025 | |
| Canon Medical Systems USA, INC. | $23.63 | 2024 | Interventional Angiography System |
| Impulse Dynamics (USA) INC. | $17.35 | 2024 | Optimizer |
| G Medical Diagnostic Services, INC. | $17.18 | 2019 | |
| Kestra Medical Technology Services, INC. | $15.78 | 2025 | Assure Wcd |
| Cook Medical LLC | $15.04 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.98 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.41 | 2019 | |
| Lilly USA, LLC | $14.23 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $12.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.